Effect of mediators of innate immunity and inflammation on CD8+ veto cells

Transplantation

Volumn 78, Issue 11, 2004, Pages 1597-1600

  Zimring, James C ^a   Chadwick, Traci E ^a   Hillyer, Christopher D ^a   Roback, John D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Tolerance; Transplantation; Veto cells

Indexed keywords

AUTACOID; DOUBLE STRANDED DNA; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; ALLOIMMUNIZATION; ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CYTOLYSIS; GRAFT SURVIVAL; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; IMMUNE TOLERANCE; IMMUNITY, NATURAL; INFLAMMATION MEDIATORS; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RNA, DOUBLE-STRANDED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 10644232940     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000144322.48212.14     Document Type: Article

References (20)

1. Sun H, Subbotin V, Chen C, et al. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation 1997; 64(12): 1838.
2. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381(6581): 434.
3. Pearson TC, Alexander DZ, Winn KJ, et al. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57(12): 1701.
4. Levisetti MG, Padrid PA, Szot GL, et al. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J Immunol 1997; 159(11): 5187.
5. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 1997; 94(16): 8789.
6. Pierson RN III, Crowe JE Jr, Pfeiffer S, et al. CD40-ligand in primate cardiac allograft and viral immunity. Immunol Res 2001; 23(2-3): 253.
7. Pearson TC, Trambley J, Odom K, et al. Anti-CD40 therapy extends renal allograft survival in rhesus macaques. Transplantation 2002; 74(7): 933.
8. Goodier MR, Londei M. Low concentrations of lipopolysaccharide synergize with peptides to augment human T-cell proliferation and can prevent the induction of non-responsiveness by CTLA4-Ig. Immunology 2001; 102(1): 15.
9. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299(5609): 1033.
10. Fink PJ, Shimonkevitz RP, Bevan MJ. Veto cells. Annu Rev Immunol 1988; 6: 115.
11. Miller RG, Muraoka S, Claesson MH, et al. The veto phenomenon in T-cell regulation. Ann N Y Acad Sci 1988; 532: 170.
12. Reisner Y, Martelli MF. Tolerance induction by 'megadose' transplants of CD34+ stem cells: A new option for leukemia patients without an HLA-matched donor. Curr Opin Immunol 2000; 12(5): 536.
13. Gur H, Krauthgamer R, Berrebi A, et al. Tolerance induction by megadose hematopoietic progenitor cells: Expansion of veto cells by short-term culture of purified human CD34(+) cells. Blood 2002; 99(11): 4174.
14. Thomas JM, Carver FM, Cunningham P, et al. Veto cells induce long-term kidney allograft tolerance in primates without chronic immunosuppression. Transplant Proc 1991; 23(1 pt 1): 11.
15. Zimring JC, Levery SB, Kniep B, et al. CD75s is a marker of murine CD8(+) suppressor T cells. Int Immunol 1389; 15(11): 1389.
16. Kaiser WJ, Kaufman JL, Offermann MK. IFN-alpha sensitizes human umbilical vein endothelial cells to apoptosis induced by double-stranded RNA. J Immunol 2004; 172(3): 1699.
17. Rich RF, Green WR. Antiretroviral cytolytic T-lymphocyte nonresponsiveness: FasL/Fas-mediated inhibition of CD4(+) and CD8(+) antiviral T cells by viral antigen-positive veto cells. J Virol 1999; 73(5): 3826.
18. Hoebe K, Janssen EM, Kim SO, et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 2003; 4(12): 1223.
19. von Herrath MG, Bot A. Immune responsiveness, tolerance and dsRNA: Implications for traditional paradigms. Trends Immunol 2003; 24(6): 289.
20. Muraoka S, Ehman DL, Miller RG. Irreversible inactivation of activated cytotoxic T lymphocyte precursor cells by "anti-self" suppressor cells present in murine bone marrow T cell colonies. Eur J Immunol 1984; 14(11): 1010.